Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Subgroups of young type 2 diabetes in India reveal insulin deficiency as a major driver

View ORCID ProfileRashmi B Prasad, Olof Asplund, Sharvari R Shukla, View ORCID ProfileRucha Wagh, Pooja Kunte, Dattatrey Bhat, Malay Parikh, Meet Shah, Sanat Phatak, Annemari Käräjämäki, Anupam Datta, Sanjeeb Kakati, Tiinamaija Tuomi, Banshi Saboo, Emma Ahlqvist, Leif Groop, View ORCID ProfileChittaranjan S Yajnik
doi: https://doi.org/10.1101/2021.05.07.21256703
Rashmi B Prasad
1Department of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö SE-205 02, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rashmi B Prasad
  • For correspondence: rashmi.prasad@med.lu.se
Olof Asplund
1Department of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö SE-205 02, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharvari R Shukla
2Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune 411011, India
3Symbiosis Statistical Institute, Symbiosis International University, Pune 411005, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rucha Wagh
2Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune 411011, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rucha Wagh
Pooja Kunte
2Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune 411011, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dattatrey Bhat
2Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune 411011, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malay Parikh
4Dia Care - Diabetes Hormone Clinic, 1 & 2, Gandhi Park, L Colony, Ambawadi, Ahmedabad, Gujarat 380015, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meet Shah
4Dia Care - Diabetes Hormone Clinic, 1 & 2, Gandhi Park, L Colony, Ambawadi, Ahmedabad, Gujarat 380015, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanat Phatak
2Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune 411011, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemari Käräjämäki
5Department of Primary Health Care, Vaasa Central Hospital, Vaasa, Finland; Diabetes Center, Vaasa Health Care Center, Vaasa, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anupam Datta
6Assam Medical College and Hospital, AMC Rd, Barbari, Dibrugarh Assam 786002, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjeeb Kakati
6Assam Medical College and Hospital, AMC Rd, Barbari, Dibrugarh Assam 786002, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiinamaija Tuomi
1Department of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö SE-205 02, Sweden
7Abdominal Center, Endocrinology, Helsinki University Central Hospital, Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland; Folkhälsan Research Center, Helsinki, Finland
8Institute for Molecular Medicine Finland FIMM, Helsinki University, Helsinki 00290, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Banshi Saboo
4Dia Care - Diabetes Hormone Clinic, 1 & 2, Gandhi Park, L Colony, Ambawadi, Ahmedabad, Gujarat 380015, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Ahlqvist
1Department of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö SE-205 02, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leif Groop
1Department of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö SE-205 02, Sweden
8Institute for Molecular Medicine Finland FIMM, Helsinki University, Helsinki 00290, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chittaranjan S Yajnik
2Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune 411011, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chittaranjan S Yajnik
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Aim/Hypothesis Five subgroups were described in European diabetes patients using a data driven machine learning approach on commonly measured variables. We aimed to test the applicability of this phenotyping in Indian young-onset type 2 diabetes patients.

Methods We applied the European derived centroids to the Indian type 2 diabetes patients diagnosed before 45 years of age from the WellGen (n = 1612) cohort. We also applied de novo k-means clustering to the WellGen cohort to validate the subgroups. We then compared clinical and metabolic-endocrine characteristics and the complication rates between the subgroups. We also compared characteristics of the WellGen subgroups with those of two young European cohorts ANDIS (n= 962) and DIREVA (n=420). Subgroups were also assessed in two other Indian cohorts, Ahmedabad (n = 187) and PHENOEINDY-2 (n = 205).

Results Both Indian and European young type 2 diabetes patients were predominantly classified into severely insulin-deficient (SIDD) and mild obesity-related (MOD) subgroups, while the severely insulin-resistant (SIRD) and mild age-related (MARD) subgroups were rare. In WellGen, SIDD (53%) was more common than MOD (38%), contrary to figures in Europeans (Swedish: 26% vs 68%, Finnish: 24% vs 71% respectively). A higher proportion of SIDD compared to MOD was also seen in Ahmedabad (57% vs 33%) and in PHENOEINDY-2 (67% vs 23%). Both in Indians and Europeans, the SIDD subgroup was characterized by insulin deficiency and hyperglycemia, MOD by obesity, SIRD by severe insulin resistance and MARD by mild metabolic-endocrine disturbances. In WellGen, nephropathy and retinopathy were more prevalent in SIDD compared to MOD while the latter had higher prevalence of neuropathy.

Conclusions /Interpretation Our data identified insulin deficiency as the major driver of type 2 diabetes in young Indians, unlike in young European patients in whom obesity and insulin resistance predominate. Our results provide useful clues to pathophysiological mechanisms and susceptibility to complications in young Indian type 2 diabetes, and suggest a need to review management strategies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by grants from the Indo-Swedish joint network grant from the Swedish Research Council and the Department of Science and Technology, India (Dnr/Reg. nr: 2015-06722) to RBP and C/3019/IFD/2018-2019 to CSY, Wellcome Trust to CSY, Swedish Research Council (2017-02688), Diabetes Wellness Sweden (25-420 PG) and the Novo Nordisk Foundation (NNF18OC0034408) to EA, Swedish Research Foundation (2015-2558) to LG, the Swedish Heart and Lung Foundation, the Crafoord Foundation, the Swedish Diabetes Foundation and the Albert Påhlsson Research Foundation. The DIREVA Study is supported by the Vasa Hospital district, The Academy of Finland (grants no. 263401, 267882, 312063 to LG, 312072 to TT), University of Helsinki, Ollqvist Foundation, Finnish Diabetes Research Foundation, Helsinki University Central Hospital Research Foundation, Jakobstadsnejdens heart foundation to AK. CSY was a visiting Professor to Danish Diabetes Academy (supported by Novo Nordisk Foundation) and Southern University of Denmark during 2016-1019.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All studies were approved by the local/regional Institutional Ethics Committees. The WellGen study was approved by the Institutional Ethics Committee, King Edward Memorial Hospital Research Centre (KEM/HRC/Dir.Off/977, 2004; KEMHRC/LGF/EC/1608A, 2017). The Ahmedabad study was approved by the regional Ethics Committee in Ahmedabad (Rudraksha/Dir.off/380015, 2020). The PHENOEINDY2 study was approved by Institutional Ethics Committee, Assam Medical College (AMC/EC/932, 2007). The ANDIS study was approved by regional ethics review committee in Scania (584/2006 and 2012/676). The DIREVA study was approved by the ethics committee in Vaasa (6/2007). All subjects gave written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available with Prof C S Yajnik and Dr Rashmi Prasad for sharing to confirm our findings and for additional analyses by applying to the corresponding author with a 200-word plan of analysis. Data sharing is subject to local/regional Institutional Ethics Committees approval and Government of India Health Ministry advisory committee permission.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Subgroups of young type 2 diabetes in India reveal insulin deficiency as a major driver
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Subgroups of young type 2 diabetes in India reveal insulin deficiency as a major driver
Rashmi B Prasad, Olof Asplund, Sharvari R Shukla, Rucha Wagh, Pooja Kunte, Dattatrey Bhat, Malay Parikh, Meet Shah, Sanat Phatak, Annemari Käräjämäki, Anupam Datta, Sanjeeb Kakati, Tiinamaija Tuomi, Banshi Saboo, Emma Ahlqvist, Leif Groop, Chittaranjan S Yajnik
medRxiv 2021.05.07.21256703; doi: https://doi.org/10.1101/2021.05.07.21256703
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Subgroups of young type 2 diabetes in India reveal insulin deficiency as a major driver
Rashmi B Prasad, Olof Asplund, Sharvari R Shukla, Rucha Wagh, Pooja Kunte, Dattatrey Bhat, Malay Parikh, Meet Shah, Sanat Phatak, Annemari Käräjämäki, Anupam Datta, Sanjeeb Kakati, Tiinamaija Tuomi, Banshi Saboo, Emma Ahlqvist, Leif Groop, Chittaranjan S Yajnik
medRxiv 2021.05.07.21256703; doi: https://doi.org/10.1101/2021.05.07.21256703

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9767)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1559)
  • Health Policy (735)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11641)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (517)
  • Oncology (1176)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4657)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)